In a recent healthcare report from The Wall Street Journal, reporter Laura Landro explores A New Prognosis for Pain Care, and the future of technologies to better measure and manage chronic pain. Maulik Nanavaty, senior vice president and president, Neuromodulation, spoke with the Journal to share perspectives on the latest developments, including the Boston Scientific Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System.
Jim Davis, a retired Marine from North Carolina whose Spectra WaveWriter SCS System “allowed him to stop using a wheelchair and start swimming and scuba diving,” also shares his story in the piece. The Boston Scientific team is proud to lead innovations in chronic pain management and offer non-opioid treatment options for Jim and others like him who suffer from chronic pain.
Read the full piece here.
Patient outcome outlined in this article may not be predictive of results in other cases. Results in other cases may vary.